International Journal of Infectious Diseases

作者在投稿时必须声明在稿件准备过程中使用了生成式人工智能工具。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

所有作者应在对以下各项均做出实质性贡献：研究的构思与设计、数据获取或数据分析与解释；撰写稿件或对其进行重要的学术内容修改；以及对提交版本的最终批准。 模型中文摘要

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

所有作者必须披露可能不当影响（偏倚）其工作的与他人或组织的任何财务和个人关系，并使用指定模板完成利益冲突声明并上传至投稿系统。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of compe…

如工作涉及人类受试者，作者应确保所描述的工作是按照世界医学协会伦理准则（赫尔辛基宣言）进行的。 模型中文摘要

If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.

文章被接受后，作者将被要求填写一份许可协议；开放获取文章的第三方再使用许可范围由作者选择的用户许可决定。 模型中文摘要

Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.

请访问开放获取页面了解本期刊开放获取出版的更多信息。 模型中文摘要

Please visit our Open Access page for more information about open access publishing in this journal.

本期刊采用单盲同行评审流程；合适的稿件通常至少送交两名独立专家评审，编辑对接受或拒绝拥有最终决定权。 模型中文摘要

This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

如预印本随后已作为同行评审出版物发表，应引用正式出版物；尚未正式发表但与工作密切相关的预印本可以引用，但须明确标注为预印本并提供预印本DOI。 模型中文摘要

Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…

自2022年9月6日起，报告研究结果的投稿须进行前瞻性系统综述注册，作者应在相关开放获取在线注册库（如PROSPERO）注册其方案。 模型中文摘要

Prospective registration of systematic reviews is required as from 6 September 2022 for any submitted manuscript reporting study results to be considered for publication in the International Journal of Infectious Diseases. Authors should register their protocols in any relevant open access online registry with searchable databases e.g. PROSPERO.